Why is Zim Laboratories falling/rising?

As of 25-Jun, Zim Laboratories Ltd is currently priced at 112.00, reflecting a decrease of 0.4, or 0.36%. The stock has underperformed its sector today by 1.41% and has experienced a consecutive decline over the last two days, resulting in a total drop of 0.69%. Despite this recent downturn, the stock has shown strong performance over the past week and month, with returns of 7.32% and 24.31%, respectively. However, the company has faced challenges, including a significant 29.5% decline in profits over the past year, despite generating a modest return of 6.67%. Additionally, the stock's long-term growth prospects appear weak, with net sales growing at only 6.41% annually over the last five years, and it has reported negative results for the last four consecutive quarters.
In the broader market context, Zim Laboratories' short-term performance has outpaced the benchmark Sensex, which has only increased by 1.61% over the past week and 1.27% over the past month. However, the stock's long-term performance remains concerning, as it has declined by 40.19% over the past three years, while the Sensex has gained 56.95% in the same period. The lack of domestic mutual fund investment, holding only 0% of the company, may indicate a lack of confidence in the stock's valuation or business prospects, further contributing to its recent price movement.